Literature DB >> 11371574

Heterotrimers formed by tumor necrosis factors of different species or muteins.

P Ameloot1, W Declercq, W Fiers, P Vandenabeele, P Brouckaert.   

Abstract

Incubation of murine tumor necrosis factor (mTNF) at subnanomolar concentrations results in partial dissociation of the trimers, coinciding with a decrease in bioactivity. Using size-exclusion chromatography, we observed that the conversion of labeled mTNF to monomers is not only prevented by coincubation with an excess of unlabeled mTNF but also with unlabeled human TNF (hTNF). Moreover, after coincubation of mTNF and hTNF four different TNF complexes were revealed by native polyacrylamide gel electrophoresis, viz. homotrimeric mTNF and hTNF, as well as two complexes with an intermediate migration pattern. Analytical gel filtration in combination with native polyacrylamide gel electrophoresis and Western blot immunodetection indicated that these new complexes consisted of heterotrimeric TNF molecules. We conclude that an exchange of monomers takes place during coincubation of two different species of TNF, which results in homotrimeric and heterotrimeric TNF. To assess receptor interaction in vitro, TNF heterotrimeric molecules were used as obtained after incubation of mTNF with labeled hTNF (which only binds to mTNF receptor I) or with labeled mutein mTNF75 (specific for mTNF receptor II). These heterotrimers were retained by both mTNF receptors, which means that the mTNF subunits incorporated in heterotrimeric complexes still can bind to both types of TNF receptor. In addition, the gradual decrease in mTNF bioactivity during preincubation at subnanomolar concentrations was prevented by the presence of mutein mTNF75, which is inactive in an L929 cytotoxicity assay, indicating that heterotrimerization can influence the overall bioactivity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371574     DOI: 10.1074/jbc.M104486200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Inhibition of 4-1BBL-regulated TLR response in macrophages ameliorates endotoxin-induced sepsis in mice.

Authors:  Bo Ram Bang; Sang Jick Kim; Hideo Yagita; Michael Croft; Young Jun Kang
Journal:  Eur J Immunol       Date:  2015-01-21       Impact factor: 5.532

2.  Three-in-one chromatography-free purification, tag removal, and site-specific modification of recombinant fusion proteins using sortase A and elastin-like polypeptides.

Authors:  Joseph J Bellucci; Miriam Amiram; Jayanta Bhattacharyya; Dewey McCafferty; Ashutosh Chilkoti
Journal:  Angew Chem Int Ed Engl       Date:  2013-02-19       Impact factor: 15.336

3.  Natural Conformational Sampling of Human TNFα Visualized by Double Electron-Electron Resonance.

Authors:  Bruce Carrington; William K Myers; Peter Horanyi; Mark Calmiano; Alastair D G Lawson
Journal:  Biophys J       Date:  2017-07-25       Impact factor: 4.033

4.  Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer.

Authors:  James O'Connell; John Porter; Boris Kroeplien; Tim Norman; Stephen Rapecki; Rachel Davis; David McMillan; Tracy Arakaki; Alex Burgin; David Fox Iii; Tom Ceska; Fabien Lecomte; Alison Maloney; Alex Vugler; Bruce Carrington; Benjamin P Cossins; Tim Bourne; Alastair Lawson
Journal:  Nat Commun       Date:  2019-12-19       Impact factor: 14.919

5.  A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF.

Authors:  Daniel J Lightwood; Rebecca J Munro; John Porter; David McMillan; Bruce Carrington; Alison Turner; Anthony Scott-Tucker; Elizabeth S Hickford; Antje Schmidt; David Fox; Alison Maloney; Tom Ceska; Tim Bourne; James O'Connell; Alastair D G Lawson
Journal:  Nat Commun       Date:  2021-01-25       Impact factor: 14.919

6.  A Rational Insight into the Effect of Dimethyl Sulfoxide on TNF-α Activity.

Authors:  Nasir Javaid; Mahesh Chandra Patra; Hana Seo; Farzana Yasmeen; Sangdun Choi
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.